Literature DB >> 33016925

Nonsuppressible HIV-1 viremia: a reflection of how the reservoir persists.

Janet D Siliciano1, Robert F Siliciano1,2.   

Abstract

Antiretroviral therapy (ART) generally reduces plasma HIV to undetectable levels, although virus persists in latently infected CD4+ T cells. In some individuals, viremia remains detectable despite adherence to ART and the absence of drug resistance mutations. In this issue of the JCI, Halvas et al. describe HIV RNA sequences from plasma of 8 donors with persistent viremia. Residual viremia was dominated by identical HIV-1 RNA sequences that remained relatively constant over 4 years. Plasma virus matched replication-competent virus cultured from CD4+ T cells. Integration site analysis confirmed the presence of large clones of infected cells. These results indicate that nonsuppressible viremia can be due to expanded clones of infected CD4+ T cells carrying replication-competent virus. The individuals described here represent extreme examples of a phenomenon that is seen in all infected individuals and that is a major barrier to curing HIV infection, the in vivo proliferation of latently infected cells.

Entities:  

Year:  2020        PMID: 33016925      PMCID: PMC7598039          DOI: 10.1172/JCI141497

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Recent trends in HIV-1 drug resistance.

Authors:  Janet D Siliciano; Robert F Siliciano
Journal:  Curr Opin Virol       Date:  2013-09-07       Impact factor: 7.090

2.  Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Authors:  Rebecca T Veenhuis; Abena K Kwaa; Caroline C Garliss; Rachel Latanich; Maria Salgado; Christopher W Pohlmeyer; Christopher L Nobles; John Gregg; Eileen P Scully; Justin R Bailey; Frederic D Bushman; Joel N Blankson
Journal:  JCI Insight       Date:  2018-09-20

Review 3.  Life expectancy living with HIV: recent estimates and future implications.

Authors:  Fumiyo Nakagawa; Margaret May; Andrew Phillips
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

4.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.

Authors:  R T Davey; N Bhat; C Yoder; T W Chun; J A Metcalf; R Dewar; V Natarajan; R A Lempicki; J W Adelsberger; K D Miller; J A Kovacs; M A Polis; R E Walker; J Falloon; H Masur; D Gee; M Baseler; D S Dimitrov; A S Fauci; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.

Authors:  Justin R Bailey; Ahmad R Sedaghat; Tara Kieffer; Timothy Brennan; Patricia K Lee; Megan Wind-Rotolo; Christine M Haggerty; Ashrit R Kamireddi; Yi Liu; Jessica Lee; Deborah Persaud; Joel E Gallant; Joseph Cofrancesco; Thomas C Quinn; Claus O Wilke; Stuart C Ray; Janet D Siliciano; Richard E Nettles; Robert F Siliciano
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.

Authors:  G Dornadula; H Zhang; B VanUitert; J Stern; L Livornese; M J Ingerman; J Witek; R J Kedanis; J Natkin; J DeSimone; R J Pomerantz
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

8.  HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Authors:  F Maldarelli; X Wu; L Su; F R Simonetti; W Shao; S Hill; J Spindler; A L Ferris; J W Mellors; M F Kearney; J M Coffin; S H Hughes
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

9.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

View more
  5 in total

1.  Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART.

Authors:  Charline Bacchus-Souffan; Mark Fitch; Jori Symons; Mohamed Abdel-Mohsen; Daniel B Reeves; Rebecca Hoh; Mars Stone; Joseph Hiatt; Peggy Kim; Abha Chopra; Haelee Ahn; Vanessa A York; Daniel L Cameron; Frederick M Hecht; Jeffrey N Martin; Steven A Yukl; Simon Mallal; Paul U Cameron; Steven G Deeks; Joshua T Schiffer; Sharon R Lewin; Marc K Hellerstein; Joseph M McCune; Peter W Hunt
Journal:  PLoS Pathog       Date:  2021-01-19       Impact factor: 6.823

2.  LILAC pilot study: Effects of metformin on mTOR activation and HIV reservoir persistence during antiretroviral therapy.

Authors:  Delphine Planas; Amélie Pagliuzza; Rosalie Ponte; Augustine Fert; Laurence Raymond Marchand; Marta Massanella; Annie Gosselin; Vikram Mehraj; Franck P Dupuy; Stéphane Isnard; Jean-Philippe Goulet; Sylvie Lesage; Eric A Cohen; Mager Peter Ghali; Jonathan B Angel; Nicolas Chomont; Jean-Pierre Routy; Petronela Ancuta
Journal:  EBioMedicine       Date:  2021-03-01       Impact factor: 8.143

3.  Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.

Authors:  Alexandre Nicolas; Julie Migraine; Jacques Dutrieux; Maud Salmona; Alexandra Tauzin; Atsuko Hachiya; Jérôme Estaquier; Jean-Michel Molina; François Clavel; Allan J Hance; Fabrizio Mammano
Journal:  Microbiol Spectr       Date:  2022-06-30

Review 4.  I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections.

Authors:  Ivona Pandrea; Kelsie Brooks; Rahul P Desai; Minali Tare; Jason M Brenchley; Cristian Apetrei
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

Review 5.  Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic.

Authors:  David A Spencer; Mariya B Shapiro; Nancy L Haigwood; Ann J Hessell
Journal:  Front Public Health       Date:  2021-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.